About Us
Branch
Beijing Yongtai Biological Products Co., Ltd.
It is an indirect wholly-owned subsidiary of the company, with a total R&D and production center area of over 30,000 square meters, mainly engaged in R&D.EAL®.
Beijing Yongtai Ruike Biotechnology Co., Ltd.
Mainly engaged in the development and application of immunotherapy, including CAR-T and TCR-T cells.
Shanghai Yongtai Immunobiological Products Co., Ltd.
Shanghai Yongtai is wholly owned by Beijing Yongtai, established to prepare for the commercialization of products in Eastern China.EAL®.
Beijing Weixiao Biotechnology Development Co., Ltd.
Beijing Weixiao is a subsidiary of Beijing Yongtai, mainly engaged in the technological development of biological products.
Ankang Ruihe Biomedical Technology (Beijing) Co., Ltd.
Mainly engaged in the technological development, technical services, and technical consulting of biomedicine.
Korea Research Center
A research center established in the Korean Science Valley, aimed at supporting the development of next-generation cancer immunotherapy products and discovering specific new products under research that can act on various cancer cells.